1. Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials. (12th June 2018) Authors: Maurer, M J; Habermann, T M; Shi, Q; Schmitz, N; Cunningham, D; Pfreundschuh, M; Seymour, J F; Jaeger, U; Haioun, C; Tilly, H; Ghesquieres, H; Merli, F; Ziepert, M; Herbrecht, R; Flament, J; Fu, T; Flowers, C R; Coiffier, B Journal: Annals of oncology Issue: Volume 29:Number 8(2018) Page Start: 1822 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗